Who
Dominic Piscitelli
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Oric Pharmaceuticals; Chief Financial Officer, AnaptysBio.
In numbers
- Trades disclosed
- 98
- Buys
- 1
- Sells
- 20
- Bought
- $322K
- Sold
- $7.8M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 24 Feb 2017
- Last trade
- 20 Oct 2026
- Last filed
- 21 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Oct 2026filed 21 Oct 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $61K14,000 at $4.36 | filing |
| 20 Oct 2026filed 21 Oct 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $189K14,000 at $13.53 | filing |
| 20 Oct 2026filed 21 Oct 2026 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —14,000 at $0.00 | filing |
| 28 Sep 2026filed 29 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $58K13,400 at $4.36 | filing |
| 28 Sep 2026filed 29 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $181K13,400 at $13.53 | filing |
| 28 Sep 2026filed 29 Sep 2026 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,400 at $0.00 | filing |
| 28 Sep 2026filed 29 Sep 2026 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,400 at $0.00 | filing |
| 28 Sep 2026filed 29 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $58K13,400 at $4.36 | filing |
| 28 Sep 2026filed 29 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $181K13,400 at $13.53 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $2,616600 at $4.36 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1,350100 at $13.50 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $6,753500 at $13.51 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —600 at $0.00 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —600 at $0.00 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $2,616600 at $4.36 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1,350100 at $13.50 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $6,755500 at $13.51 | filing |
| 26 Aug 2026filed 28 Aug 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $227K52,000 at $4.36 | filing |
| 26 Aug 2026filed 28 Aug 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $150K25,000 at $6.00 | filing |
| 26 Aug 2026filed 28 Aug 2026 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1.1M77,000 at $13.69 | filing |
News
Oric Pharmaceuticals (NASDAQ:ORIC) CFO Dominic Piscitelli Sells 14,000 Shares of Company Stockthemarketsdaily.com · 22 Oct 2026ORIC Pharmaceuticals Plans Phase 3 Trial For Enozertinib After Promising Lung Cancer DataORIC · rttnews.com · 23 Oct 2026Oric Pharmaceuticals (NASDAQ:ORIC) CFO Dominic Piscitelli Sells 14,000 Shares of Company StockORIC · themarketsdaily.com · 22 Oct 2026
1 headline in the last 90 days name Dominic Piscitelli; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.